Community-associated strains of methicillin-resistant staphylococcus aureus and methicillin-susceptible S. aureus in indigenous northern Australia: Epidemiology and outcomes

Journal of Infectious Diseases

Volumn 199, Issue 10, 2009, Pages 1461-1470

  Tong, Steven Y C ^a,b   Bishop, Emma J ^a   Lilliebridge, Rachael A ^a   Cheng, Allen C ^a   Spasova Penkova, Zornitsa ^c   Holt, Deborah C ^a   Giffard, Philip M ^a   McDonald, Malcolm I ^a   Currie, Bart J ^a,b   Boutlis, Craig S ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b Northern Territory Clinical School   (Australia)

^c ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FUSIDIC ACID; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ABORIGINE; ADULT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SEX DIFFERENCE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; PATIENT SELECTION; PROSPECTIVE STUDIES; RISK FACTORS; SEASONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS;

EID: 65549090640     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598218     Document Type: Article

References (44)

1. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993; 25:97-108.
2. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol 2000; 38:3926-31.
3. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 2003; 7:259-67.
4. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996; 164:721-3.
5. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286:1201-5.
6. Baggett HC, Hennessy TW, Leman R, et al. An outbreak of communityonset methicillin-resistant Staphylococcus aureus skin infections in Southwestern Alaska. Infect Control Hosp Epidemiol 2003; 24:397-402.
7. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-8.
8. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976-84.
9. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-15.
10. McDonald M, Dougall A, Holt D, et al. Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote Aboriginal communities. J Clin Microbiol 2006; 44:3720-7.
11. de Lencastre H, Oliveira D, Tomasz A. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol 2007; 10:428-35.
12. Nimmo GR, Coombs GW, Pearson JC, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184:384-8.
13. Tong SY, McDonald MI, Holt DC, Currie BJ. Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clin Infect Dis 2008; 46:1871-8.
14. Munckhof WJ, Nimmo GR, Carney J, et al. Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillinresistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 2008; 27:355-64.
15. Popovich K, Hota B, Rice T, Aroutcheva A, Weinstein RA. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007; 45:2293-95.
16. Coombs GW, Pearson JC, O'Brien FG, Murray RJ, Grubb WB, Christiansen KJ. Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis 2006; 12:241-7.
17. Australian Bureau of Statistics. Northern Territory at a glance, 2007. Available at: http://www.abs.gov.au/AUSSTATS/abs@nsf/Lookup/1304.7Main- Features12007?OpenDocument. Accessed 23 October 2008.
18. Chondur R, Guthridege S, Lee H. Socio-economic indexes for areas (SEIFA) of administrative health districts and urban centres/localities in the Northern Territory. Darwin, Australia: Department of Heatlh and Community Services, 2005. Available at: http://digitallibrary.health.nt .gov.au/dspace/bitstream/10137/ 119/1/seifa-info-paper-final.pdf. Accessed 23 October 2008.
19. Trewin D. Information paper: ABS views on remoteness (report no. 1244.0). Canberra, Australia: Australian Bureau of Statistics, 2001. Available at: http://www.ausstats.abs.gov.au/ausstats/free.nsf/0/FCC8158C85 424727CA256C0F00003575/$File/12440-2001.pdf. Accessed 23 October 2008.
20. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of communityassociated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42:647-56.
21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
22. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; 6th edition. M7-A6. Wayne, PA: CLSI, 2003.
23. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11:554-61.
24. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198:336-43.
25. Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007; 39:6-13.
26. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillinsusceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471-82.
27. Davis SL, Perri MB, Donabedian SM, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007; 45:1705-11.
28. Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and-susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44:483-92.
29. Wang JL, Chen SY, Wang J-T, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to communityacquired methicillin-resistant Staphylococcus aureus and methicillinsusceptible S. aureus. Clin Infect Dis 2008; 46:799-806.
30. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of communityacquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002; 21:910-7.
31. Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillin-susceptible and methicillinresistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007; 54:427-34.
32. Miller LG, Diep BA. Colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:752-60.
33. Peacock SJ, Justice A, Griffiths D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41: 5718-25.
34. McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian Aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006; 43:683-89.
35. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-91.
36. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med 2007; 167:1026-33.
37. Clucas DB, Carville KS, Connors C, Currie BJ, Carapetis JR, Andrews RM. Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ 2008; 86:275-81.
38. Diep B, Stone G, Basuino L, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008; 197:1523-30.
39. Gorwitz R. Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. J Infect Dis 2008; 197:179-82.
40. Zhang K, McClure J-A, Elsayed S, Tan J, Conly J. Coexistence of Panton-Valentine leukocidin-positive and-negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. J Infect Dis 2008; 197:195-204.
41. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-9.
42. Dohin B, Gillet Y, Kohler R, et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007; 26:1042-8.
43. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect 1998; 38:273-81.
44. Nimmo GR, Coombs GW. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 2008; 31:401-10.